Author

Roberto Piva

University of TurinORCID 0000-0002-2273-3470Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Organism:zebrafish· 1

Frequent Co-Authors

Alessandra LaroccaiD· 1 shared Annalaura TamburriniiD· 1 shared Beatrice LucianoiD· 1 shared Benedetto BrunoiD· 1 shared Cecilia BandiniiD· 1 shared Domenico MaisanoiD· 1 shared Elisabetta MereuiD· 1 shared Eugenio MorelliiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alessandra LaroccaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Bedaquiline Amplifies Proteasome Inhibitor Efficacy and Overcomes Resistance in Multiple Myeloma

Michela Cumerlato, Monica Maccagno, María Labrador, Beatrice Luciano, Elisabetta Mereu, Mariangela Porro, Cecilia Bandini, Mattia Furlan, Domenico Maisano, Mattia D’Agostino, Alessandra Larocca, Francesca Maria Gay, Annalaura Tamburrini, Francesca Anselmi, Paolo Ettore Porporato, , Roberto Piva

This paper identifies bedaquiline as a synergistic agent that enhances proteasome inhibitor efficacy and overcomes resistance in multiple myeloma and related B-cell malignancies.

Haematologica · Apr 23, 2026Peer-reviewedCancer Biology